T-MSIS provider-level spending data, Jan 2018 – Dec 2024
SARS-CoV-2 (COVID-19) antigen, rapid test
Total Paid
$707.8M
$707,822,084
Beneficiaries
23.1M
23,148,692
Avg $/Claim
$26
Utilization
1.2 claims/bene
1,077 providers
Each dot is a state. X = average cost per claim. Y = total spending.
Drag to zoom into a region
| # | State | Total Paid▼ | Avg $/Claim | Claims | Beneficiaries | Providers |
|---|---|---|---|---|---|---|
| 1 | TX | $136.9M | $33 | 4,206,695 | 3,602,111 | 1,353 |
| 2 | NY | $67.7M | $25 | 2,716,320 | 2,308,435 | 753 |
| 3 | PR | $60.6M | $39 | 1,551,525 | 1,368,476 | 645 |
| 4 | CA | $33.4M | $20 | 1,698,021 | 1,488,265 | 821 |
| 5 | TN | $23.8M | $28 | 859,973 | 745,059 | 354 |
| 6 | KY | $23.5M | $21 | 1,115,868 | 991,297 | 396 |
| 7 | MI | $22.9M | $27 | 862,240 | 783,991 | 472 |
| 8 | NC | $22.0M | $29 | 753,664 | 550,801 | 444 |
| 9 | MS | $21.6M | $25 | 859,157 | 710,747 | 438 |
| 10 | MD | $20.5M | $27 | 770,362 | 663,827 | 252 |
| 11 | LA | $20.1M | $23 | 872,646 | 673,312 | 396 |
| 12 | OK | $20.1M | $40 | 506,069 | 494,042 | 289 |
| 13 | VA | $19.9M | $22 | 920,208 | 843,957 | 341 |
| 14 | SC | $18.5M | $47 | 394,201 | 369,465 | 235 |
| 15 | NJ | $17.9M | $22 | 801,411 | 633,541 | 353 |
| 16 | FL | $16.2M | $10 | 1,644,015 | 1,373,557 | 641 |
| 17 | IN | $14.7M | $25 | 601,887 | 505,166 | 207 |
| 18 | OH | $13.0M | $20 | 656,566 | 575,824 | 304 |
| 19 | IL | $13.0M | $28 | 468,451 | 370,940 | 911 |
| 20 | AL | $11.2M | $20 | 574,661 | 493,944 | 407 |
| 21 | AR | $10.0M | $32 | 314,950 | 269,226 | 361 |
| 22 | PA | $9.8M | $27 | 358,114 | 337,395 | 615 |
| 23 | CT | $9.0M | $26 | 343,572 | 291,913 | 89 |
| 24 | GA | $8.6M | $26 | 328,466 | 308,361 | 159 |
| 25 | NM | $8.2M | $34 | 240,510 | 230,861 | 92 |
57 rows · Page 1 of 3